Skip to main content
. 2017 Jul 25;8(41):71249–71284. doi: 10.18632/oncotarget.19531

Table 1. Properties of the main vectors used in gene therapy protocols.

Vector Integrative in vitro delivery efficiency in vivo delivery Efficiency Capacity to trigger immune response Efficient production
Adenoviral No High High High Yes
Lentiviral Yes High High Low No
Retroviral Yes High High Low No
AAV No High High High No
Liposomes No High Low Low Yes

Abbreviations: AAV, Adeno-associated virus.